Therapeutic vaccines for cancer: an overview of clinical trials


The therapeutic potential of host-specific and tumour-specific immune responses is well recognized and, after many years, active immunotherapies directed at inducing or augmenting these responses are entering clinical practice. Antitumour immunization is a complex, multi-component task, and the optimal combinations of antigens, adjuvants, delivery vehicles… (More)
DOI: 10.1038/nrclinonc.2014.111


3 Figures and Tables

Cite this paper

@article{Melero2014TherapeuticVF, title={Therapeutic vaccines for cancer: an overview of clinical trials}, author={Ignacio Melero and Gustav Gaudernack and Winald R. Gerritsen and Christoph Huber and Giorgio Parmiani and Suzy M. E. Scholl and Nicholas Thatcher and John Wagstaff and Christoph C. Zielinski and I. J. Faulkner and H{\aa}kan Mellstedt}, journal={Nature Reviews Clinical Oncology}, year={2014}, volume={11}, pages={509-524} }